Featured Products & Services
-
Bionanoparticle Technology
4/24/2023
Nanoform’s proprietary bionanoparticle technology can deliver large-molecule drug particles as small as 50 nm while retaining biological activity. This can not only enable more patient-friendly approaches to drug delivery, but also potentially higher loads of active ingredients.
-
NovaSeptum® GO Sterile Sampling Systems
10/17/2019
From your bioreactor to final sterile filtration, the new NovaSeptum® GO sampling system lets you sample processes the way you want. Flexible formats and volumes adapt to your process for robust, reliable monitoring and quality assurance.
-
New Solutions For Large Molecule Analysis
6/16/2023
Explore Biozen LC Portfolio
With a new titanium BioTi™ biocompatible hardware to minimize priming, four particle platforms for optimal versatility and nine particle chemistries to maximize selectivity and sensitivity, Biozen UHPLC/HPLC columns are seamlessly designed to bring peace of mind to your analysis of biologics through:
- Charge Variant Analysis
- Aggregate Analysis
- Peptide Mapping
- Intact Mass Intact and Fragment Analysis
- Glycan Analysis
- Peptide Quantitation
- Drug Antibody Ratio (DAR)
- Oligonucleotide Characterization
-
Novotech Drug Development Consulting: Services For Success
6/27/2023
Delve into the details of this full-service global product development and strategic regulatory group that has a proven track record of successful FDA meetings and approvals.
-
Plasmid DNA Production
6/23/2022
Integrated manufacturing supporting cell and gene therapies.
The critical genetic foundation for advanced therapies
Plasmid DNA is a critical raw material for advanced therapies and mRNA synthesis, supporting their transfection to enable rapid advancement of the therapeutic product. Center for Breakthrough Medicines (CBM) offers capacity dedicated to the development and manufacture of high quality plasmid DNA and other nucleic acids.
-
Labscale Lipid Nanoparticle Production: IJM NanoScaler
12/9/2024
The benchtop IJM NanoScaler system is designed for lipid nanoparticle R&D – allowing scientists to screen for the optimal process parameters for the formulation of API-containing lipid nanoparticles.
-
Oligonucleotide Synthesizer
2/10/2023
Synthesize oligonucleotides at scales of 10–100 mmol for early to mid-phase clinical trials or for diagnostic kits.
-
Closed Robotic Isolator For Pharmaceutical Vial Filling
3/23/2023
The Microcell™ Vial Filler is a closed robotic isolator for pharmaceutical vial filling that enables small batch flexibility and standardized manufacturing.
-
Clinical And Regulatory Strategy
11/7/2023
Many biotechnology companies come to Australia to conduct early phase clinical trials and take advantage of straightforward regulatory streams and of the lucrative 43.5% R&D cash refund scheme. Biotechnology companies then often look at locations in Asia, such as South Korea, Thailand and China to tap into their huge treatment-naïve patient populations for their later phase clinical research.
-
Infectious Diseases And Vaccines CRO Services
6/27/2023
Many biotechnology companies look at the Asia-Pacific region for their trials in Infectious diseases and Vaccines due to the high prevalence of diseases such as Hepatitis (Hepatitis B, Hepatitis C), HIV, and Influenza across the region.